Home
Menu
LinkedIn
Logo: Adare Pharma Solutions
  • Quick Links
    • Learn About Our Precision Particle Fabrication® Technology
    • Explore Careers at Adare Pharma Solutions
    • Read About Our Latest News & Events
    • Knowledge Center

Patient-Centric Solutions

  • Overview
  • Taste Masking
  • Customized Release
  • Bioavailability Enhancement

Microbiome

Newsroom

Events

Knowledge Center

Technologies

  • Overview
  • AdvaTab®
  • Diffucaps®
  • Diffutab®
  • Microcaps®
  • Minitabs®
  • Optimμm®
  • Orbexa™
  • Parvulet™
  • Stratμm®
  • Unisun®

Manufacturing

  • Overview

Development Services

  • Overview
  • Precision Particle Fabrication®

Quality & Regulatory

Customer-Focused Support

About Us

  • Our Legacy
  • Our Leadership
  • Our People

Careers

Contact Us

Medical Inquiries

Current Openings

Italy

 
  • Careers
    • France
    • Canada
    • Italy
    • United States
  • Latest News
    • 09-22-20 THOMAS H. LEE PARTNERS AND FRAZIER HEALTHCARE PARTNERS ACQUIRE ADARE

      Boston, MA and Seattle, WA - September 22, 2020 Transaction includes specialty CDMO business, including pharmaceutical technology and microbiome... Learn More

    • 05-04-20 Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

      Lawrenceville, NJ, and Lenexa, KS - May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual... Learn More

    • 01-13-20 Adare Pharmaceuticals and NLS Pharmaceutics collaborate to develop mazindol controlled release (CR) for the treatment of ADHD and narcolepsy

      Lawrenceville, NJ & Switzerland - January 13, 2020 Adare Pharmaceuticals, Inc. (Adare) and NLS Pharmaceutics Ltd. (NLS) announced today a collaboration... Learn More

    • 04-15-19 Adare acquires Egalet’s proprietary “Parvulet™” technology platform

      Princeton, NJ & Wayne, PA - April 15, 2019 Adare Pharmaceuticals, Inc. today announced that it has entered into an agreement with Egalet Corporation... Learn More

    • View all

Our clients and customers benefit from our unmatched experience in specialized oral solid dose technologies. And now, with the addition of the innovative delivery systems developed by Orbis Biosciences, we’re delivering injectable solutions that provide even more opportunities.

— Ajay Damani, VP, Business Unit Leader – Pharmaceutical Technologies

Adare Pharma Solutions

CORPORATE OFFICES

Headquarters:
Princeton Pike Corporate Center
1200 Lenox Drive, Suite 100
Lawrenceville, NJ 08648
USA
+1 (609) 450-1312
597, Boul. Laurier
Mont-Saint-Hilaire, QC
Canada, J3H 6C4
+1 (450) 600-1414

MANUFACTURING

Via Martin Luther King, 13
20060 Pessano con Bornago (MI)
Italy
+39 02 954281
Via Molise, 16
20098 San Giuliano Milanese (MI)
Italy
+39 02 988981-200
Route de Bû
78550 Houdan
France
+33 (0)1 30 46 19 00

DEVELOPMENT & MANUFACTURING

845 Center Drive
Vandalia, Ohio 45377
USA
+1 (937) 898-9669
8006 Reeder Street
Lenexa, KS 66214
USA

©2021 Adare Pharma Solutions. All rights reserved

  • Privacy Policy
  • Terms & Conditions
  • Contact Us